A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen

NCT01107756 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

403

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms (no Otherwise Specified)

Interventions

DRUG: LENOGRASTIM (GRANOGYTE 34)

Sponsor

Sanofi